Secondary Stock OfferingsBy The Online Investor Staff, updated Thu., Oct. 18, 8:43 PM
|This Slide: #2 of 25|
Slide #2. OpGen, Inc. — Secondary Offering
OpGen, Inc. (NASDAQ:OPGN)
Date of Pricing:
Price Per Share:
Secondary Offering Details:
OpGen, Inc. (NASDAQ: OPGN) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are being offered by OpGen, Inc. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. -updated 10/18- OpGen, Inc. (NASDAQ: OPGN) today announced the pricing of an underwritten public offering of approximately 2.2 million shares of its common stock at a public offering price of $1.45 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 330,751 shares to cover overallotments in connection with the offering. The gross proceeds to OpGen from this offering, before deducting underwriting discounts and commissions and offering expenses payable by OpGen, are expected to be approximately $3.2 million. The offering is expected to close on or about October 22, 2018, subject to customary closing conditions.
OpGen is precision medicine company using molecular diagnostics and informatics to combat infectious disease. Co.'s product offerings include its QuickFISH and PNA FISH products, which are vitro diagnostic tests designed to identify antimicrobial resistant pathogens, its Acuitas multidrug-resistant organism (MDRO ) Gene Test, Acuitas CR Elite Test and Acuitas Resistome Test, each a lab-based test that provides a profile of MDRO resistant genes for surveillance and response to outbreaks, and its Acuitas Lighthouse informatics, which provides trend analysis of patient specific data, data specific to individual hospital facilities and health systems.
Open the OPGN Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 86% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite